Ovarian Cancer Risk Associated with Inherited Inflammation-Related Variants

Kristin L. White, Joellen M. Schildkraut, Rachel T. Palmieri, +21

Cancer Research

Genetic EpidemiologyImmunologyPathologyGynecologyOvarian Cancer Risk +16

Xenobiotic‐Metabolizing gene polymorphisms and ovarian cancer risk

Ellen L. Goode, Kristin L. White, Robert A. Vierkant, +11

Molecular Carcinogenesis

Cancer RiskCancer EpidemiologyIllumina GoldengateGeneticsOvarian Carcinogenesis +11

Candidate Gene Analysis Using Imputed Genotypes: Cell Cycle Single-Nucleotide Polymorphisms and Ovarian Cancer Risk

Ellen L. Goode, Brooke L. Fridley, Robert A. Vierkant, +16

Cancer Epidemiology Biomarkers & Prevention

Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes

Abraham Peedicayil, Robert A. Vierkant, Lynn C. Hartmann, +20

PLoS ONE

Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.

Prema P. Peethambaram, Brooke L. Fridley, Robert A. Vierkant, +10

PubMed

Ovarian Cancer OutcomeCancer PathologyEpidemiology Of CancerGenetic EpidemiologyPathology +14

Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality

Ellen L. Goode, Georgia Chenevix‐Trench, Lynn C. Hartmann, +38

Cancer Epidemiology Biomarkers & Prevention

Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome

Kristin L. White, Robert A. Vierkant, Zachary C. Fogarty, +4

Cancer Epidemiology Biomarkers & Prevention

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer

Kristin L. White, Robert A. Vierkant, Catherine M. Phelan, +12

BMC Cancer

Variation at 8q24 and 9p24 and Risk of Epithelial Ovarian Cancer

Kristin L. White, Thomas A. Sellers, Brooke L. Fridley, +16

Twin Research and Human Genetics

Bayesian mixture models for the incorporation of prior knowledge to inform genetic association studies

Brooke L. Fridley, Daniel Serie, Gregory D. Jenkins, +4

Genetic Epidemiology